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The crystal structures of trans,trans-Ethyl-5-(4
-chlorophenylsulfonyl)-4-hydroxy-2,6-dip-tolyl-
1,2,5,6-tetrahydropyridine-3-carboxylate (Ia) and cis-
D i e t h y l  4 -h y d r o x y - 2 - ( 4 -n i t r o p h e n y l ) -5 -
(phenylsulfonyl)-6-(phenylsulfonylmethyl)cyclohexa-
3,6-diene-1,3-dicarboxylate (Ib) were elucidated by 
single crystal X ray diffraction. Compound (Ia) 
C28H28Cl NO5S, crystallizes in the monoclinic system, 
space group P 21/c, with a = 9.4530(7) Å, b = 25.366
(2) Å, c = 11.4353(8) Å, β = 103.092(7)°, V = 2670 (3) 
Å3 and   Z = 4. The compound (Ib), C31H29N1O11S2, 
crystallizes in the monoclinic system, space group P 
21/c, with a = 21.179(4) Å, b = 8.4998(16) Å, c = 
17.347(3) Å, β = 102.563(3)°, V = 3048.0(10) Å3 and 
Z = 4. The central piperidine ring of compound (Ia) 
adopts the sofa conformation and the central cyclo-
hexadiene ring of compound (Ib) adopts the boat con-
formation.  Details of the compounds preparation, 
crystal structures and hydrogen bonding interactions of 
the compounds are discussed. 
Research Article 
J. Suresh1, P.S. Harikrishnan2, R. Vishnu Priya1 and S. Perumal3 
1Department of Physics, The Madura College (Autonomous), Madurai 625 011, India 
2Department of Chemistry, The Madura College (Autonomous) , Madurai, 625 011, India 
3School of Chemistry, Madurai Kamaraj University, Madurai, 625 021, India 
Received on April 20, 2012; Accepted on June 22, 2012; Published on October 18, 2012 
Correspondence should be addressed to J. Suresh; Email: ambujasureshj@yahoo.com 
Crystal structural studies of ethyl-5-(4-chlorophenylsulfonyl)-4-hydroxy-2, 6-dip-
tolyl-1, 2, 5, 6-tetrahydropyridine-3-carboxylate and diethyl 4-hydroxy-2-(4-
nitrophenyl)-5-(phenylsulfonyl)-6-(phenylsulfonylmethyl)cyclohexa-3,6-diene-1,3-
dicarboxylate 
Introduction 
 
The 2,6-disubstituted-1,2,5,6-tetrahydropyridine skele-
ton is present in only a few natural products (Angle et 
al. 1995, Wang et al. 1992). Aspertin A and B, isolated 
from Andrachne aspera, a small perennial undershrub, 
is commonly found in the arid, stony and sandy re-
gions of Pakistan (Ahmad et al. 2002, Nasir et al. 
1972). Medicinally, this plant is used to improve eye-
sight and to treat eye sores (Satiyanati et al. 1976, 
Hoppe et al. 1975). (+)-Cannabisativine is an unusual 
macrocyclic spermidine alkaloid containing a trans-2,6
-disubstituted-1,2,5,6-tetrahydropyridine ring, which 
was isolated from the roots and leaves of the common 
marijuana plant Cannabis sativa L  (Lotter et al. 1975). 
Another member of this class of alkaloids, (-)-
palustrine (Karrer et al. 1948), a toxic component of 
the horsetail plant Equisetum paluster L., found in the 
meadows of Europe, has been isolated as it has a se-
dum alkaloid called (-)-sedacrine (Bates et al. 2002). 
Tetrahydropyridine derivatives are useful against sev-
eral metabolic disorders and human ailments and are 
involved in the monoamine oxidase-based mechanism 
related to Parkinson’s disease (Beeler et al. 2003, 
Deskus et al. 2007). They also act as inhibitors of far-
nesyl transferase (Gwaltney et al. 2003) and dihydro-
orate dehydrogenase (Kamei et al. 2005).  
 Cyclohexa-1,4-diene derivatives have attracted 
considerable attention due to their wide range of appli-
cations, besides serving as building blocks for the syn-
thesis of natural products such as (±)-vibralactone 
(Zhou et al. 2008), DL-proto-quercitol and DL-gala-
quercitol (Salamci et al. 1997), DL-gala-
aminoquercitol (Kurbanoglu et al. 2010), scyphostatin 
(Fujioka et al. 2002), (+)-/(–)-cryptocaryones (Fujioka 
et al. 2010) and (–)-myriocin (Inai et al. 2008). 
The core Cyclohexane unit is either prepared 
from natural sources or entirely via synthetic routes. Its 
derivatives are known to have several medical uses. 
They provide anticonvulsant, antimalarial, anti-
inflammatory and cardiovascular effects (Aridoss et al. 
2011, Eddington et al. 2000). Some of them also have 
fungicidal and antitumor activities (Li & Strobel, 
2001). The pharmacological effects of potential new 
drugs depend entirely on the stereochemistry and ring 
conformations of the compounds. Taking these aspects 
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into consideration, and in order to obtain detailed in-
formation on the molecular structure in the solid state, 
an X-ray study of the title compounds (Ia) and (Ib) 
was carried out. 
 Recently our research group reported the syn-
thesis and evaluation of the anti-mycobacterial activi-
ties of (i) 4-(2,4-dichlorophenyl)-5-phenylpyrrolo
(spiro[2.2'']acenaphthene-1''-one) spiro[3.2']-6'-(2,4-
dichlorophenylmethylidene)cyclohexanone (Ranjith 
Kumar et al. 2009) (ii) spiro[5.2'']acenaphthene-1''-
onespiro[6.2']-6'-(2,dichlorophenylmethylidene) cyclo-
hexanone-7-(2,4-dichlorophenyl)tetrahydro-1H-
pyrrolo[1,2-c][1,3]thiazole (Ranjith Kumar et al. 2009) 
and (iii) 4H-pyrano[3,2-c] pyridine derivatives 
(Ranjith Kumar et al. 2007). In the course of finding 
new compounds that could be useful for the chemo-
therapy of tuberculosis, we identified the compounds 
(Ia) and (Ib).  In order to establish the structure-
function relationships, we have carried out X-ray dif-
fraction experiments in order to obtain detailed infor-
mation on the molecular structure in the solid phase. 
We also performed an NMR study on these com-
pounds in the liquid state. 
 
Experimental 
 
For the preparation of compound (Ia) ,  a mixture of 
ethyl 4-(4-chlorophenylsulfonyl)-3-oxobutanoate (1 
mmol), freshly distilled p-methylbenzaldehyde (2 
mmol) and ammonium acetate (2 mmol) in ethanol (10 
ml) was warmed at 600C for 5 min. The reaction mix-
ture was then kept at room temperature. After 3 days, 
the separated solid was filtered and purified by flash 
chromatography (4:1 petroleum ether- ethyl acetate) 
affording a colorless solid. (Yield: 81%; Melting-
point: 155-156°C). 
 For the preparation of compound (Ib), a mix-
ture of ethyl 3-oxo-4-(phenylsulfonyl)butanoate (2 
mmol), 4-nitrobenzaldehyde (1mmol) and ammonium 
acetate (0.25 mmol) in ethanol (10 ml) was warmed at 
60°C for 5 min. The reaction mixture was then kept at 
room temperature. After 3 days, the separated solid 
was filtered and purified by flash chromatography (4:1 
petroleum ether-ethyl acetate) affording a colorless 
solid. (Yield: 78% melting-point: 152-153°C). 
 
Structure Determination and Refinement  
 
Single crystal X-ray intensity data for compound (Ia) 
and compound (Ib) were collected using a Bruker 
SMART APEX CCD diffractometer with Mo Kα ra-
diation (λ=0.71073Å)  at room temperature (293 K). 
The data reduction was performed with SAINT 
(Bruker 2001). An absorption correction was made 
using the ω-scan method. The structure of both com-
pounds were solved using the direct method 
SHELXS97 (Sheldrick 1990) and all the non-hydrogen 
atoms were refined anisotropically by full matrix least-
squares, based on the F2 taking all the unique reflec-
tions using SHELXL97 (Sheldrick 2008). Molecular 
graphics were drawn using PLATON (Spek 2003). 
The hydrogen atoms were placed in calculated posi-
tions and included in the refinement using the riding 
model with C—H = 0.93–0.98, O—H = 0.82 Å and 
Uiso = 1.2Ueq(C,) for CH, CH2 groups and Uiso = 
1.5Ueq(C) for CH3 and OH groups. The crystal data, 
experimental conditions and structure refinement pa-
rameters for the compounds (Ia) and (Ib) are presented 
in Tables 1 and 2. The molecular structures of the 
compounds (Ia) and (Ib) showing the atom numbering 
scheme using ORTEP 3 (Farrugia 1997) are shown in 
Figure 1. 
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Empirical formula C28 H28 Cl N O5S 
Formula weight 526.02 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group P 21/c, monoclinic 
Unit cell dimensions a = 9.4530(7) Å, α = 90° 
  b = 25.366(2) Å, β = 
103.092(7)° 
  c = 11.4353(8), γ = 90° 
Volume 2670.7(3)Å 3 
Z, Calculated density 4, 1.308 mg/m3 
Absorption coefficient 0.259 mm-1 
F(000) 1104 
Crystal size 0.19x0.16x0.14mm3 
Theta range for data collec-
tion 
2 .7 to 26.00 deg 
Limiting indices -11<=h<=11,-31,=k<=31 
-14<=l<=14 
Reflections collected / 
unique 
52339 / 5245[R(int) = 
0.0539] 
Completeness to theta 99.9% 
Absorption correction ω-scan 
Refinement method Full-matrix least-squares on 
F2 
 
Data / restraints / parame-
ters 
 
 
5245 / 0 / 330 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma
(I)] 
R1 = 0.0654, wR2 = 0.1795 
R indices (all data) R1 = 0.0884, wR2 = 0.2018 
Largest diff. peak and hole 0.810 and -0.674 e Å -3 
Table 1. The crystal data, experimental conditions and 
structure refinement parameters of compound (Ia).  
Results and Discussion 
 
In compound (Ia), C28 H28 Cl N O5 S, the piperidinone 
ring adopts the sofa conformation as indicated by the 
puckering parameters Q = 0.4558 Å,   θ = 52.91 (13)° 
and Φ = 5.8170° (Cremer & Pople 1975). In the central 
ring, the nitrogen N1 atom is deviating by -0.619(3) Å 
from the least-squares plane defined by the atoms (C2/
C3/C4/C5/C6). The methoxy phenyl rings are equato-
rially oriented at dihedral angles of 83.11(1)° and 
65.70(1)° with respect to the best (C2/C3/C4/C5/C6) 
plane in the central piperidone ring . The dihedral an-
gle between the two [(C21—C27) and (C61—C67)] 
methoxy phenyl rings is 53.09(1)°. The ethoxycar-
bonyl group at C5 is nearly perpendicular to the 
methyl phenyl ring at C6, forming a dihedral angle of 
79.94(2)°. 
 The sum of the bond angles around the N1 
[346.91(4)°] atom of the tetrahydropyridine ring in the 
molecule is consistent with the sp2hybridization. 
Figure 2 shows a partial packing view of the 
compound (Ia) down to a-axis. An intra molecular O--
-H…O and inter molecular N---H…O hydrogen bonds 
are found.                 
  An intermolecular C---H…π interaction C23–
H23…Cg1 (-1+x, y, z) is found (Cg1 is the centroid of 
C31-C36 ring). There are no π-π interactions. Table 3 
lists the inter- and intra- molecular hydrogen bonding. 
The N---H…O hydrogen bonds generate a graph set 
motif C1
1(7) (Bernstein et al. 1995) that is shown in 
Figure 3. 
 In the compound (Ib), C31H29N1O11S2, the cen-
tral cyclohexadiene ring adopts the boat conformation, 
as indicated by the puckering parameters Q = 0.181(4) 
Å, θ = 81.4 (13)° and Φ = 229.7(12)° (Cremer & Pople 
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Figure 1. The molecular structure of compounds (Ia) (left) and (Ib) (right) showing the atom numbering scheme. Displacement 
ellipsoids are drawn at 30% probability level, using ORTEP 3. Hydrogen atoms are drawn as spheres of arbitrary size.  
Empirical formula C31H29N1O11S2, 
Formula weight 655.67 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group P 21/c,  monoclinic 
Unit cell dimensions a = 21.179(4) Å, α = 90° 
  b =  8.4998(16) Å,   β = 
102.563(3)° 
  c = 17.347 (3) Å, γ = 90° 
Volume 3048.0(10) Å3 
Z, Calculated density 4,  1.429 mg/m3 
Absorption coefficient 0.238 mm-1 
F(000) 1368 
Crystal size 0.17x0.14x0.11mm3 
Theta range for data collec-
tion 
0.99  to 26.00 deg 
Limiting indices -26<=h<26,-10<=k<10, 
-21<=l<=21 
Reflections collected / 
unique 
27594 / 5975[Rint = 0.0455] 
Completeness to theta 99.7% 
Absorption correction ω-scan 
Refinement method Full-matrix least-squares on 
F2 
Data / restraints / parame-
ters 
5975 / 0 / 409 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma
(I)] 
R1 = 0.0667, wR2 = 0.1828 
R indices (all data) R1 = 0.0921, wR2 = 0.2038 
Largest diff. peak and hole 0.476 and -0.307 eÅ -3 
Table 2. The crystal data, experimental conditions and 
structure refinement parameters of compound (Ib).  
1975). In the central ring , atoms C2 and C5 are deviat-
ing by -0.117(5) Å and 0.189(5) Å, respectively, from 
the least-squares plane defined by the atoms C1/C3/
C4/C6. The dihedral angle between the two adjacent 
[(C51—C56) and (C62—C67)] phenyl sulfonyl rings 
is 55.1(1)°. The ethoxycarbonyl group at C1 is equato-
rially oriented to the C2 nitrophenyl ring making a di-
hedral angle of 77.73(1)°. 
 Table 4 lists the inter- and intra-molecular hy-
drogen bonding interactions. Numerous C-H…O hy-
drogen bonds are found to stabilize the structure. There 
are no π-π interactions. The crystal packing of the 
molecules down to the b-axis is shown in Figure 4. 
The C (53)-H (53)...O (2) hydrogen bond generating a 
graph set motif of R4
4(30) (Bernstein et al. 1995) is 
shown in Figure 5.  
 
 
Spectral data 
 
The identity of the compounds (Ia) and (Ib) has been 
ascertained by NMR spectral data. A detailed analysis 
of the two-dimensional NMR spectra has helped assign 
the hydrogens and carbons of interest in these com-
pounds. The numbering scheme for carbons and hy-
drogens given here for the NMR data and the crystal 
structure is used for convenience and is not the ac-
cepted way of numbering according to IUPAC rules. 
The 1H, 13C and the 2D NMR spectra were 
recorded on a Bruker (Avance) 300 MHz NMR instru-
ment using TMS as an internal standard and CDCl3 as 
a solvent. Standard Bruker software was used through-
out. Chemical shifts are given in parts per million (δ-
scale) and the coupling constants are given in hertz. 
 
Compound (Ia) 
trans,trans-Ethyl 5-(4-chlorophenylsulfonyl)-4-
hydroxy-2,6-di-p-tolyl-1,2,5,6-tetrahydropyridine-3
-carboxylate (Ia)  
The –CH3 protons (H-9) of the ester group appear as a 
triplet at 0.79 ppm with the coupling constant J= 6.9 
Hz and the –CH2 protons (H-8) appear as a multiplet 
between 3.62-4.02 ppm. The two singlets at 2.32 and 
2.34 ppm were assigned to two methyl groups (H-27 & 
H-67) attached to phenyl groups. The H-2 & H-3 ap-
pears as a broad singlet at 4.35 ppm (2H) and H-6 as a 
singlet at 5.01 ppm. A multiplet between 7.07 – 7.26 
ppm (8H), the two doublets at 7.54 ppm (2H) & at 
7.94 ppm (2H) with the coupling constant J = 8.1 Hz 
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Figure 3. Linear Chain pattern C1
1(7) of compound (Ia) in 
the crystal structure. 
Figure 2. Partial packing diagram of the compound (Ia) 
viewed down to ‘a’ axis. For clarity only selected atoms are 
shown. 
D-H…A D-H H…A D…A D-H…A 
O(3)-H(3A)…O(1) 0.82 1.89 2.597(3) 144 
N(1)-H(1)…O(5)(i) 0.92 2.22 3.1244(3) 165 
C(23)-H(23)…Cg1(ii) 0.92 2.98 3.794(2) 147 
Table 3. Hydrogen bonds [Å and°].* 
Figure 4. Partial packing diagram of the compound (Ib) 
viewed down to ‘b’ axis. For clarity only selected atoms are 
shown. 
*The symmetry transformations used to generate equivalent 
atoms are the following: 
      (i) x, 1/2-y,-1/2+z 
      (ii) -1+x,y,z 
were due to the aromatic hydrogens. A broad singlet at 
12.23 ppm was assigned due to the H-3A proton. The 
aliphatic methyl carbon signal appears at 13.8 ppm (C-
9) and aromatic methyl carbon signals at 21.4 & 21.5 
ppm.(C-27 & C-32). There are three aliphatic CH car-
bon signals at 53.6, 53.9 & 66.9 ppm (C-2, C-6 & C-3) 
and six aromatic CH carbon ones at 127.3, 128.2, 
129.3, 129.8, 129.9 & 131.1 ppm. The  peak at 61.2 
was due to the CH2 (C-8) carbon. Quaternary carbon 
signals were assigned as follows: C-4 at 160.9, C-5 at 
107.5 and C-7 at 171.2 ppm. Others appear at 136.2, 
137.3, 137.9, 138.2, 139.9 & 141.3 ppm. 
 
Compound Ib 
Cis-Diethyl 4-hydroxy-2-(4-nitrophenyl)-5-
(phenylsulfonyl)-6-[(phenylsulfonylmethyl]-3,6-
cyclohexadiene -1,3-dicarboxylate 
The –CH3 protons (at H-33 & H-9) of the ester group 
appear as a triplet at 0.79 ppm (coupling constant J = 
7.2 Hz) and 1.15 ppm (coupling constant J = 5.7 Hz), 
respectively. The –CH2 protons of the ester group (H-
32) appear as a multiplet between 3.97-4.07 ppm and 
as a quartet (C-8) with the coupling constant J = 7.2 
Hz. The –CH2 (H-61A & H-61B) protons undergo 
geminal coupling with the coupling constant J = 14.1 
Hz and appear as doublets at 4.74 & 5.28 ppm. The 
protons H-2 & H-5 undergo long range coupling with 
the coupling constant      J = 3.9 Hz and appear as dou-
blets at 5.14 and 5.32 ppm, respectively. The aromatic 
protons signal appears as follows: a multiplet between 
7.54 – 7.73 ppm (6H) and the four doublets at 7.76 
(2H, J = 8.7 Hz), 7.83 (2H, J = 8.1 Hz), 7.99 (2H, J = 
8.1 Hz) and 8.13 ppm (2H, J = 8.7 Hz). A broad 
singlet at 12.20 ppm was assigned due to the H-1 pro-
ton. The ester methyl carbon signals (C-9 & C-33) ap-
pear at 13.8 and 13.9 ppm.  There are two aliphatic CH  
carbon signals at 44.4 (C-2) & 69.8 ppm (C-5) and 
eight aromatic CH carbon signals at 128.1, 128.8, 
129.3, 129.5, 130.6, 134.2, 134.5 & 138.3 ppm. The 
peak at 57.7 ppm is due to the CH2  (C-61) carbon. The 
ester CH2 carbon signals appear at 61.7 (C-32) and 
62.0 ppm (C-8). Quaternary carbon signals  were as-
signed as follows: C-2 at 141.5, C-4 at 160.4, C-3 at 
102.5, C-7 at 164.5 and C-31 at 170.2 ppm. Others 
appear at 121.9, 123.3, 140.1, 146.5 and 147.1 ppm.  
 
Conclusion 
 
trans,trans-Ethyl 5-(4-chlorophenylsulfonyl)-4-
hydroxy-2,6-di-p-tolyl-1,2,5,6-tetrahydropyridine-3-
carboxylate and cis-Diethyl 4-hydroxy-2-(4-
n i t r o p h e n y l ) - 5 - ( p h e n y l s u l f o n y l ) - 6 -
[(phenylsulfonylmethyl]-3,6-cyclohexadiene-1,3-
dicarboxylate were synthesized. The single crystals of 
the compounds (Ia) and (Ib) were obtained by the 
slow evaporation method (solvent: 4:1 petroleum ether
-ethyl acetate). The conformational features of these 
compounds in the solid and liquid phase were analysed 
by X-ray diffraction and NMR, respectively. Further 
studies on structure-activity relationships of these 
compounds are in progress in our research group. 
 
Supplementary Material 
 
Crystallogtaphic data (excluding structure factors) for 
the structures of (Ia) and (Ib) reported in this paper 
have been deposited with the Cambridge Crystallo-
graphic data Centre as supplementary publication no. 
CCDC 838483 and CCDC 860790. Copies of the data 
can be obtained, free of charge, on application to, 
CCDC, 12 Union Road, Cambridge, and CB2 1 EZ 
UK; Fax: 044-1223-336033; Email: de-
posit@ccdc.cam.uk or at: http://www.ccdc.cam.ac.uk/. 
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Figure 5. Ring pattern R4
4(30) formed by intermolecular H-
bonds is observed in the crystal packing of compound (Ib). 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(1)-H(1)...O(6) 0.82 1.83 2.536(4) 143 
C(5)-H(5)...O(11) 0.98 2.31 3.112(5) 139 
C(22)-H(22)...O(9) 0.93 2.35 3.271(5) 169 
C(61)-H(61A)...O(2) 0.97 2.13 2.896(6) 135 
C(61)-H(61B)...O(8) 0.97 2.24 2.962(5) 131 
C(53)-H(53)...O(2) (i) 0.93 2.52 3.208(6) 131 
C(8)-H(8A)...O(10)(ii) 0.97 2.6 3.518(7) 159 
Table 4. Hydrogen bonds [Å and°].* 
  
*The symmetry transformations used to generate equivalent 
atoms are the following: 
(i) x, −y−1/2, z+1/2 
(ii) x, −y−1/2, z+1/2 
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